• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CXSL2400018 人干扰素α2b阴道泡腾片 Recombinant Human Interferon α2b Tablet Biological Products(2.2) New Drug Application 2024-01-10 Beijing Kawin Technology Share-Holding Co Ltd view
CXSL2400016 人干扰素α2b阴道泡腾片 Recombinant Human Interferon α2b Tablet Biological Products(2.2) New Drug Application 2024-01-09 Beijing Kawin Technology Share-Holding Co Ltd view
CYSB2200184 人干扰素α2b阴道泡腾片 Recombinant Human Interferon α2b Tablet Biological Products Supplementary Application 2022-07-28 Beijing Kawin Technology Share-Holding Co Ltd view
CYSB1800231 重组人干扰素α2b阴道泡腾片 Recombinant Human Interferon α2b Tablet Biological Products Supplementary Application 2018-10-29 北京凯因科技股份有限公司 Beijing Kawin Technology Share-Holding Co Ltd Certificate Issued 2020-11-03 view
CXSS0900044 重组人干扰素α2b阴道泡腾片 Recombinant Human Interferon α2b Tablet Biological Products(13) New Drug Application 2010-01-15 北京凯因科技股份有限公司 Beijing Kawin Technology Share-Holding Co Ltd Certificate Issued 2012-11-06 view
CXSS0600022 重组人干扰素α2b阴道泡腾片 Recombinant Human Interferon α2b Tablet Biological Products New Drug Application 2006-02-13 深圳市海王英特龙生物技术股份有限公司 Shenzhen Neptunus Interlong BIO-TECHNIQUE Co Ltd Certificate Issued 2008-01-10 view
X0406708 重组人干扰素α2b阴道泡腾片 Recombinant Human Interferon α2b Tablet Biological Products(13) New Drug Application 2004-11-17 北京凯因生物技术有限公司 Beijing Kawin Technology Share-Holding Co Ltd Certificate Issued 2005-07-08 view
X0401661 重组人干扰素α2b阴道泡腾片 Recombinant Human Interferon α2b Tablet Biological Products New Drug Application 2004-04-07 深圳市海王英特龙生物技术股份有限公司 Shenzhen Neptunus Interlong BIO-TECHNIQUE Co Ltd Certificate Issued 2004-10-15 view